SPYRE THERAPEUTICS, INC. Contract Liability (Deferred Revenue)
SPYRE THERAPEUTICS, INC. (SYRE) had Contract Liability (Deferred Revenue) of $0 as of 2023-12-31, per its 10-K/A filed 2024-11-18.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:ContractWithCustomerLiabilityCurrent · last filed 2024-11-18
- 2023-12-31: Contract with Customer, Liability, Current $0.00.
- 2023-09-30: Contract with Customer, Liability, Current $0.00.
- 2023-06-30: Contract with Customer, Liability, Current $3.27M.
- 2023-03-31: Contract with Customer, Liability, Current $2.64M.
| Period end | Contract with Customer, Liability, Current | Contract with Customer, Liability, Current as first filed |
|---|---|---|
| 2023-12-31 | $0.00 10-K/A · filed 2024-11-18 | |
| 2023-09-30 | $0.00 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $3.27M 10-Q · filed 2023-08-11 | |
| 2023-03-31 | $2.64M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $517.00K 10-K/A · filed 2024-11-18 | $2.70M 10-K · filed 2023-03-02 |
| 2022-09-30 | $2.68M 10-Q · filed 2022-11-03 | |
| 2022-06-30 | $2.66M 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $2.81M 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $3.58M 10-K · filed 2023-03-02 | |
| 2021-09-30 | $0.00 10-Q · filed 2022-11-03 | $6.41M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $0.00 10-Q · filed 2022-08-04 | $7.80M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $0.00 10-Q · filed 2022-05-05 | |
| 2020-12-31 | $0.00 10-K · filed 2023-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |